Liver Diseases Therapeutics Market - Global Industry Analysis, Size, Share- 2018

3.4.3.2 FDA approvals and other government regulations 3.4.3.3 Availability of alternate treatment procedures 3.4.4 LIVER DISEASE THERAPEUTICS MARKET RESTRAINTS IMPACT ANALYSIS 3.4.5 OPPORTUNITIES 3.4.5.1 Strong pipeline drugs 3.4.5.2 Emerging economies in Asia, Latin America and Eastern European countries 3.4.5.3 Consolidation opportunities in the healthcare industry 3.5 PORTER’S FIVE FORCES ANALYSIS FOR LIVER DISEASES THERAPEUTICS MARKET 3.5.1 BARGAINING POWER OF SUPPLIERS 3.5.2 BARGAINING POWER OF BUYERS 3.5.3 THREAT OF NEW ENTRANTS 3.5.4 THREAT OF SUBSTITUTES 3.5.5 COMPETITIVE RIVALRY CHAPTER 4 LIVER DISEASES CLASSIFICATION AND THERAPY OPTIONS 4.1 ALCOHOL INDUCED LIVER DISEASE 4.1.1 OVERVIEW 4.1.2 EPIDEMIOLOGY 4.1.3 ETIOLOGY 4.1.4 SYMPTOMS 4.1.5 PATHOPHYSIOLOGY 4.1.6 TREATMENT PATTERN AND THERAPY OPTIONS 4.1.6.1 Anabolic Steroids 4.1.6.2 Alcohol Abuse Drugs 4.2 AUTOIMMUNE LIVER DISORDER 4.2.1 AUTOIMMUNE HEPATITIS (AIH) Browse Report: http://www.transparencymarketresearch.com/liver-diseasestherapeutics.html